Brief: Synlogic Partners With Science 37 On Pivotal Study For Phenylketonuria

Synlogic

11/07/2023 13:15

July 11 (Reuters) - Science 37 Holdings Inc  SNCE.O :
    * SYNLOGIC PARTNERS WITH SCIENCE 37 ON PIVOTAL STUDY
FOR INVESTIGATIONAL DRUG FOR PHENYLKETONURIA (PKU)
    * SCIENCE 37 - SYNLOGIC EXPECTS TO ENROL ABOUT 150 PATIENTS
WHO
HAVE POTENTIAL TO RECEIVE INVESTIGATIONAL DRUG AND TO BE
MONITORED FOR UP TO THREE YEARS
    * SCIENCE 37- SCIENCE 37 METASITE WILL EXPAND ACCESS TO
TRIAL FOR
PATIENTS WHO MAY BE UNABLE OR PREFER NOT TO TRAVEL TO RESEARCH
SITES FOR STUDY VISITS

Source text for Eikon:  ID:nGNXbgR458 
Further company coverage:  SNCE.O 

 ((Reuters.Briefs@thomsonreuters.com;))